News
Zacks.com on MSN11m
AstraZeneca Rides Oncology Momentum With Blockbuster and New Drugs
AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback